ДЕФЕКТ ФИЛАГГРИНА ПРИ АТОПИЧЕСКОМ ДЕРМАТИТЕ И СОВРЕМЕННЫЕ МЕТОДЫ КОРРЕКЦИИ
Ключевые слова:
атопический дерматит, кожный барьер, филагрин, эмоленты, филагринолАннотация
Атопический дерматит-распространенное хроническое заболевание кожи, патогенез которого во многом связан с врожденным или приобретенным дефицитом белка филаггрина. В последние годы было получено много данных о причинах дефицита флаггрина. Структура и функции этого белка были описаны, что открывает новые возможности для преимуществ лечения атопического дерматита.
Библиографические ссылки
Атопический дерматит: клинические рекомендации. — 2020. [Atopicheskii dermatit: Clinical guidelines.(InRuss).] Доступно по: https://nrcii.ru/specialistam/klinrecommend/atopic_dermatitis_2020.pdf. Ссылка активна на 24.09.2022.
Čepelak I, Dodig S, Pavić I. Filaggrin and atopic march.Biochem Med (Zagreb). 2019;29(2):214–227. doi: https://doi.org/10.11613/bm.2019.0205
Tominaga M, Takamori K. Itch and nerve fibers with special reference to atopic dermatitis: Therapeutic implications. J Dermatol. 2014;41(3):205–212. doi: https://doi.org/10.1111/ 1346-8138.12317
Kido-Nakahara M, Furue M, Ulzii D, Nakahara T. Itch in Atopic Dermatitis. Immunol Allergy Clin North Am. 2017;37(1):113–122. doi: https://doi.org/10.1016/j.iac.2016.08.007
Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):792–799. doi: https://doi.org/10.1016/j.jaci.2014.06.014
Dale BA, Presland RB, Lewis SP, et al. Transient Expression of Epidermal Filaggrin in Cultured Cells Causes Collapse of Interme diate Filament Networks with Alteration of Cell Shape and Nuclear Integrity.J Invest Dermatol. 1997;108(2):179–187. doi: https://doi.org/ 10.1111/1523-1747.ep12334205
Stout TE, McFarland T, Mitchell JC, et al. Recombinant filaggrin is in - ternalized and processed to correct filaggrin deficiency. J Invest Der ma tol. 2014;134(2):423–429. doi: https://doi.org/10.1038/jid.2013.284
McAleer MA, Jakasa I, Raj N, et al. Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and
plasmin activity: implications for atopic dermatitis. Br J Dermatol. 2018;179(2):431–441. doi: https://doi.org/10.1111/bjd.16691
Garrett JP, Hoffstad O, Apter AJ, Margolis DJ. Racial comparison of filaggrin null mutations in asthmatic patients with atopic dermatitis in a US population. J Allergy Clin Immunol. 2013;132(5):1232–1234. doi: https://doi.org/10.1016/j.jaci.2013.07.005
Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-offunction mutations. J Allergy Clin Immunol. 2014;134(4):867–875. doi: https://doi.org/10.1016/j.jaci.2014.08.011
Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387: 1109–1122. doi: https://doi.org/10.1016/S0140-6736(15)00149-X
Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011, 365(14): 1315–1327. doi: https://doi.org/10.1056/NEJMra1011040
Brauweiler AM, Bin L, Kim BE, et al. Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal a-toxin-induced keratinocyte death. J Allergy Clin Immunol. 2013;131:421–427.e1–e2. doi: https://doi.org/10.1016/j.jaci.2012.10.030
Seltmann J, Roesner LM, von Hesler FW, et al. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. J Allergy Clin Immunol. 2015;135(6):1659–1661. doi: https://doi.org/10.1016/j.jaci.2015.01.048
Kim BE, Bin L, Ye YM, et al. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol.2013;133:2678–2685. doi: https://doi.org/10.1038/jid.2013.223
Kim JH, Bae HC, Ko NY, et al. Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) phosphorylation in keratinocytes. J Allergy Clin Immunol. 2015;136(1):205–208.e9. doi: https://doi.org/10.1016/j.jaci.2015.04.026
Pellerin L, Henry J, Hsu CY, et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol. 2013;131(4):1094–1102. doi: https://doi.org/10.1016/j.jaci.2012.12.1566
Amano W, Nakajima S, Kunugi H, et al. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. J Allergy Clin Immunol. 2015;136(3):667–677.e7. doi: https://doi.org/ 10.1016/j.jaci.2015.03.051
Wollenberg A, Ehmann LM. Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema. Ann Dermatol. 2012;24(3):253.doi: https://doi.org/10.5021/ad.2012.24.3.253
Amat F, Soria A, Tallon P, et al. New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview. Clin Exp Allergy. 2018;48(8):919–934. doi: https://doi.org/10.1111/cea.13156
Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi: https://doi.org/10.1111/jdv.14891
Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016;138(2):350–358. doi: https://doi.org/10.1016/j.jaci.2016.06.002
Man MQ, Barish GD, Schmuth M, et al. Deficiency of PPARbeta/ delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol. 2008;128(2):370–377. doi: https://doi.org/10.1038/ sj.jid.5701026
Granato L. Modulator from fractions of vegetable unsaponifiables.Personal Care. 2012;09:69–72.
Alimjanovich , R. Z., Maxammatkulovich , R. N., & Khikmatovich , K. K. (2022). Age Features of the Prevalence of Prostate Cancer in Uzbekistan. Central Asian Journal of Medical and Natural Science, 3(5), 154-157. Retrieved from
Rizaev Jasur , Rakhimov Nodir , Kodyrov Khamidullo , Shakhanova Shakhnoza . Study of prostate cancer death by regions of the republic of Uzbekistan.Journal of Biomedicine and Practice. 2022, vol . 7, issue 5, pp.202-210
Nodir RM, Shaxnoza SS, Farhod R. Development of new approaches in the treatment of metastatic renal cell carcinoma //Journal of research in health science. – 2020. – T. 5. – no. 4. – pp. 82-95.
ShSh Shakhanova , NM Rakhimov. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer . Clinical and Experimental Oncology 2020, No. 4 Page 50-56.
Mirraximova M. X. et al. Night of atopic dermatitis in children komorbid laboratory-immunological properties //IMRAS. – 2023. – Т. 6. – №. 6. – С. 301-306.
26.Kh M. M., Kurbanova D. R., Nishanbaeva N. Y. Identification of clinical and laboratory changes of the gastrointestinal tract in atopic dermatitis in children and improvement of the principles of diagnosis and treatment/ISSN 2181-712X.
